Kusatsu/Shiga, JapanーMay 8, 2026ーTakara Bio Inc. (Takara Bio) announces that it will present its research findings at the Annual Meeting of the American Society of Gene ＆ Cell Therapy (ASGCT), to be held from May 11 to 15, 2026, in Boston, Massachusetts, U.S.A.
|
Title & Presentation Date and Time（Local time） |
|
(Poster No. 1009) May 12 at 17:00～18:30 Neuronal transduction mechanism analysis of AAV2-derived CereAAV.YN vector |
|
(Poster No. 1057) May 12 at 17:00～18:30 Simplified gene modified T-cell production using RetroNectin® and the G Rex® platform |
|
(Poster No. 1439) May 12 at 17:00～18:30 AAV-Based Gene Therapy and Genome Editing Targeting GJB2-Related Hearing Loss through Capsid and Promoter Engineering |
|
(Poster No. 2032) May 13 at 17:00～18:30 Systemic administration of SonuAAV reveals myotropic biodistribution and its association with integrin-mediated entry |
